Optimized expression of hpv 58 l1 in yeast
    4.
    发明申请
    Optimized expression of hpv 58 l1 in yeast 有权
    酵母中优化hpv 58 l1的表达

    公开(公告)号:US20070036824A1

    公开(公告)日:2007-02-15

    申请号:US10579111

    申请日:2004-11-10

    IPC分类号: A61K39/12 C12N15/86 C12N1/18

    摘要: Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV58 VLPs. The vaccines of the present invention provide effective imnunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and are also useful for treatment of existing HPV infections.

    摘要翻译: 提供编码HPV58 L1蛋白的合成DNA分子。 具体地,本发明提供了编码HPV58L1蛋白的多核苷酸,其中所述多核苷酸在酵母细胞中用于高水平表达的密码子优化。 合成分子可用于产生HPV58病毒样颗粒(VLP),以及产生包含HPV58 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫提供了对乳头瘤病毒感染的有效预防,并且也可用于治疗现有的HPV感染。

    Optimized expression of hpv 45 l1 in yeast
    6.
    发明申请
    Optimized expression of hpv 45 l1 in yeast 有权
    酵母中优化hpv 45 l1的表达

    公开(公告)号:US20060240040A1

    公开(公告)日:2006-10-26

    申请号:US10573330

    申请日:2004-09-24

    IPC分类号: A61K39/12 C12N1/18 C12N15/74

    摘要: Synthetic DNA molecules encoding the HPV45 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV45 L1 protein, wherein said polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV45 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV45 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.

    摘要翻译: 提供了编码HPV45 L1蛋白的合成DNA分子。 具体地,本发明提供了编码HPV45 L1蛋白的多核苷酸,其中所述多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV45病毒样颗粒(VLP),以及产生包含HPV45 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。

    Codon-optimized papilloma virus sequences
    8.
    发明申请
    Codon-optimized papilloma virus sequences 有权
    密码子优化的乳头状瘤病毒序列

    公开(公告)号:US20060177817A1

    公开(公告)日:2006-08-10

    申请号:US10551057

    申请日:2004-03-19

    摘要: Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.

    摘要翻译: 提供编码HPV31 L1蛋白的合成DNA分子。 具体地,本发明提供编码HPV31 L1蛋白的多核苷酸,其中所述多核苷酸不含被酵母识别的内部转录终止信号。 还提供了编码HPV31 L1的合成多核苷酸,其中多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV31病毒样颗粒(VLP),以及生产包含HPV31 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。